Having performed particularly strongly during 2021, as the rate of COVID-19 infections in the country spiked, retail constant value sales (2022 prices) of analgesics exhibited a marginal decline in 2022. A sharp fall in the incidence of the virus was the main driver of this. However, demand was supported to a degree by a spike in cases during the early part the year. Moreover, even many of those who did not contract the virus sought to stockpile analgesics as a precautionary measure.
The Analgesics in Indonesia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
The Analgesics in Indonesia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Analgesics market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
ANALGESICS IN INDONESIAKEY DATA FINDINGSCONSUMER HEALTH IN INDONESIADISCLAIMERDEFINITIONS
2022 DEVELOPMENTS
PROSPECTS AND OPPORTUNITIES
CATEGORY DATA
EXECUTIVE SUMMARY
MARKET INDICATORS
MARKET DATA
APPENDIX
SOURCES